43 Production Lines
High-throughput automated systems optimized for zero-defect manufacturing.
capabilities
Advancing diagnostic innovation through Scientific Platforms, Integrated R&D, and Manufacturing Excellence.
Scientific Platforms
Six core technology platforms supporting innovation across diagnostic development.
6
Scientific Platforms
01
/
06
Immunochromatography
Rapid lateral flow diagnostics for clinical and point-of-care testing.
Reagent & Material Platforms
Genetic Recombinant Protein Engineering
In-house development of recombinant antigens, antibodies, and humanized antibodies for diagnostic and quality control applications.
0
Production Lines
0
test units
0
IN-HOUSE MATERIALS
Manufacturing Excellence
Our fully automated manufacturing ecosystem ensures global reliability and rapid scalability, meeting the highest international standards for quality and supply.
Proven Large-Scale Capacity
Since 2020, cumulative production has exceeded 297 million test units, demonstrating strong large-scale manufacturing and supply capabilities.
Certifications & Intellectual Property
